BANZEL (rufinamide) is a prescription medication approved for the adjunctive treatment of seizures associated with LGS in children 4 years and older and adults.
Information for patients
BANZEL offers two formulations for administration. BANZEL tablets are available in two strengths: 200 mg and 400 mg. And, BANZEL is available in an oral suspension formulation.
BANZEL tablets
BANZEL tablets are scored and can be can be cut in half and — if necessary — can be crushed. BANZEL tablets should be taken with food. Keep BANZEL tablets in a dry place and protect them from moisture.
BANZEL oral suspension
BANZEL oral suspension is supplied as an orange-flavored liquid containing 40 mg/mL of the medication. BANZEL oral suspension contains carbohydrates. It does not contain lactose or gluten and is dye-free. This formulation provides an option for patients who may prefer a liquid or have concerns about taking the medication in tablet form.
Before every administration, the oral suspension should be shaken well, and it should be taken with food. Be sure to replace the cap securely after opening. Keep BANZEL oral suspension in an upright position and use BANZEL oral suspension within 90 days of first opening the bottle.
BANZEL Oral Suspension Dosing Instructions
Take BANZEL exactly as your healthcare provider tells you. Your healthcare provider will tell you how much BANZEL to take.
If you or a loved one is prescribed BANZEL as a part of LGS therapy, be sure to talk to your healthcare provider about the possible risks and side effects associated with the use of BANZEL. It’s important to read the Medication Guide and important safety information below and discuss them with your healthcare provider.
NEXT: BANZEL Side Effects